Adjuvant for vaccine immunotherapy of cancer – focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|12|1659-1668

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.12, 2015-12, pp. : 1659-1668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Newcastle disease virus co‐expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy

Cancer Science, Vol. 109, Iss. 2, 2018-02 ,pp. : 279-288

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification of novel Lck‐derived T helper epitope long peptides applicable for HLA‐A2+ cancer patients as cancer vaccine

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1493-1498

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synthesis and characterization of rod-like Y₂O₃ and Y₂O₃:Eu³⁺

By Feldmann C. Merikhi J.

Journal of Materials Science, Vol. 38, Iss. 8, 2003-04 ,pp. : 1731-1735

Springer Publishing Company

Access to resources Recommend Favorite

Antibodies induced by multi-epitope vaccine showed inhibitory activity against heterologous influenza A virus (H3N2)*

By Jian Ding Fan Wu Wei Wei Yinghua Chen

Progress in Natural Science, Vol. 16, Iss. 1, 2006-01 ,pp. : 105-108

Taylor & Francis Ltd

Access to resources Recommend Favorite

Downregulation of dual‐specificity tyrosine‐regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin‐dependent kinase 14 expression in breast cancer

Cancer Science, Vol. 109, Iss. 2, 2018-02 ,pp. : 363-372

John Wiley & Sons Inc

Access to resources Recommend Favorite